Business Strategy for Pharmaceuticals/Drugs in Taiwan

The market for pharmaceuticals/drugs in Taiwan is approximately $4.5 billion.

Western pharmaceutical/drug companies are using multiple business strategies in Taiwan today. While a number of foreign manufacturers are selling or planning to sell their drugs and pharmaceuticals in Taiwan, others are sourcing/manufacturing, doing R+D, and performing clinical trials. Should a foreign drug company set up a representative office, branch office, joint venture, or a subsidiary in Taiwan today?

PBM will study the various opportunities for your pharmaceutical/drug products and come up with the best strategy for you.

For more information on developing your Taiwan business strategy, please see the following PBM publications and/or contact us to discuss your specific needs.

Managing Asian Cultural Diversity: Cross-Cultural Issues in Asia (webcast for sale)
Taiwan's New Universal Health Insurance Program
Opportunities in the Taiwanese Medical Market